Use of methylnaltrexone and related compounds
US6274591A · kind A · utility
70Cited by
22References
30Claims
0Family size
Inventors
Key dates
| Filing date | Jul 22, 1998 |
| Grant date | Aug 14, 2001 |
| Priority date | — |
| Expiry date | Jul 22, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for preventing or treating the opioid induced side effect, inhibition of gastrointestinal motility is disclosed. The method comprises administering methylnaltrexone or another quaternary derivative of noroxymorphone to a patient prior to the administration of an opioid or after the onset of side effects induced by the administration of an opioid, wherein the methylnaltrexone or quaternary derivative is administered orally in an enterically coated form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.